70 Percent Of Food Produce Sold In The US Contains Pesticide Residues, Even After Washing
March 26, 2019
Video Archive
March 27, 2019

Purdue Pharma Reaches $270 Million Settlement In Opioid Drug Lawsuit

NEWS

Purdue Pharma, manufacturer of the notorious OxyContin opioid drug, has agreed to pay $270 million in order to avoid taking part in a televised trial over its role in the U.S. opioid addiction epidemic.

COMMENT

As much as Purdue Pharma might hope otherwise, its legal problems in relation to OxyContin are far from over. Seen by many observers as being largely responsible for the rise of the opioid addiction epidemic in the United States, the company and its founders, the Sackler family, are now said to be facing upwards of 1,600 lawsuits.

And as if their role in the opioid crisis itself wasn’t bad enough, evidence is also emerging that, having already earned vast sums of money from OxyContin, Purdue and the Sacklers were allegedly looking into the possibility of profiting from supposedly ‘solving’ the very crisis they had helped cause. A recent New York Times article describes how a scheme called ‘Project Tango’ was apparently hatched with the goal of increasing Purdue’s profits still further through selling drug treatments for opioid addiction.

The sooner the pharmaceutical ‘business with disease’ is consigned to the dustbins of history and replaced with a truly preventive system of healthcare based on science-based natural approaches, the better it will be for all mankind.

Read article in the New York Times (USA)
English